刊物主题:Oncology; Pharmacology/Toxicology; Cancer Research;
出版者:Springer Berlin Heidelberg
ISSN:1432-0843
卷排序:79
文摘
PurposeTo evaluate the safety, tolerability, pharmacokinetics, and efficacy of the intravenously administered pan-PI3K inhibitor copanlisib in Japanese patients with advanced or refractory solid tumors.